Senile osteoporosis: Pathophysiology and therapeutic perspectives

Aging Clinical and Experimental Research

Volumn 9, Issue 4 SUPPL., 1997, Pages 77-78

  Isaia, G C ^a   Di Stefano, M ^a   Ardissone, P ^a   Roggia, C ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN;

AGED; ANIMAL; FEMALE; HUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; REVIEW;

AGED; ANIMALS; DIPHOSPHONATES; ESTROGENS; FEMALE; HUMANS; OSTEOPOROSIS;

EID: 0031307306     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03339718     Document Type: Article

References (5)

1. Manolagas S.C., Jilka R.L.: Bone marrow, cytokines and bone remodelling. N. Engl. J. Med. 332: 305-311, 1995.
2. Girasole G., Jilka R.L., Passeri G., et al.: 17-beta-estradiol inhibits interleukin-6 production by bone marrow derived stromal cells and osteoblast in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89: 883-891, 1992.
3. Jilka R.L., Hangoc G., Girasole G., et al.: Increase osteoclast development after estrogen loss; mediation by interleukin-6. Science 257: 88-91, 1992.
4. Liberman U.A., Weiss S.R., Broil J., et al.: Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N. Engl. J. Med. 333: 1437-1443, 1995.
5. Colditz G.A., Hankinson S.E., Hunter D.J., et al.: The use of estrogens and progestins and the risk of breast cancer in post-menopausal women. N. Engl. J. Med. 332:1589-1593, 1995.